CClinicalTrials.gg
Status unknownNCT05816161Updated Apr 18, 2023

Integrated Neuromuscular Inhibition Technique and Myofascial Release on Cervical Range of Motion and Dysfunction

An interventional study of Integrated Neuromuscular Inhibition Technique and Myofascial Release in Myofascial Trigger Point Pain, sponsored by Superior University. Status unknown at 1 site in Pakistan. Open to participants aged 25 Years to 40 Years. Per ClinicalTrials.gov, last updated 2023-04-18.

Sponsored by Superior University · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Apr 2023), so the status shown — last known as Enrolling by invitation — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
25 Years to 40 Years
Sex
All
01

Study summary

to findout the improvement by Integrated Neuromuscular Inhibition Technique and Myofascial Release on Cervical Range of Motion and Dysfunction

02

Conditions studied

  • Myofascial Trigger Point Pain
03

In context

Myofascial Pain Syndromes

1,136 studies on the registry are indexed under Myofascial Pain Syndromes; 137 are open to participants now.

This study's planned enrollment of 30 is below the median of 60 across 931 interventional studies indexed under Myofascial Pain Syndromes.

Browse Myofascial Pain Syndromes studies →

Lead sponsor

Superior University is the lead sponsor of 243 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ● Age between 25-40

    • Both males and females included
    • Participants suffering from recent cervical pain without any pathology.

Exclusion criteria

Exclusion Criteria:

  • ● Participants having cervical radiculopathy

    • Having recent trauma of the cervical spine
    • Non-cooperative subject
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Neuromuscular Inhibition Technique

    Diagnostic Test: Integrated Neuromuscular Inhibition Technique

  • Other
    Myofascial Release

    Diagnostic Test: Myofascial Release

Interventions

  • Diagnostic testIntegrated Neuromuscular Inhibition Technique

    Exercises

  • Diagnostic testMyofascial Release

    Exercises

06

What researchers measure

Primary outcomes

  1. Cervical Range of Motion measurement

    Time frame: 6 Months

07

Study locations

1 site
  • Chaudhary Muhammad Akram Hospital
    Lahore, Punjab, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05816161
Lead sponsor
Superior University
Responsible party
Muhammad Naveed Babur (Principal Investigator, Superior University) — Principal investigator
First posted
Apr 18, 2023
Start date
Apr 1, 2023
Primary completion
Jun 1, 2023 (estimated)
Completion
Aug 31, 2023 (estimated)
Last update
Apr 18, 2023

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion